INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer
Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.
-
Ensure The Safe And Efficient Development Of High Potent Drug Products
As your product transitions from clinical phases to commercial launch, flexible, globally compliant facilities stand ready to adapt to your evolving needs.
-
Unified Patient Apps: The Future Of Trial Simplicity
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
Better RTSM UX = Happy Clinical Trial Sites
See how thoughtful RTSM design can ease site workloads, reduce support needs, and elevate staff satisfaction. Learn why intuitive user experiences quietly strengthen trial execution.
-
Transform Your Clinical Trials With Central eSource3/25/2026
Accelerate your trial startup and reduce site burden with a central eSource that allows sponsors to develop and publish central source templates to sites.
-
When Should You Rescue Your Clinical Trial From A Bad RTSM?4/28/2026
Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.
-
How Many Vendors Does One Trial Really Need?7/13/2026
Operational friction can hinder trial performance. Discover how centralizing key functions improves coordination, lowers administrative burden, and enhances stakeholder experiences.
-
Accelerator™ Drug Development 360° CDMO And CRO Solutions3/4/2026
Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch8/7/2025
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
Developing cutting-edge treatments for ovarian cancer requires specialized expertise and a people-first approach to research.